NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
National Academies of Sciences, Engineering, and Medicine; Health and Medicine Division; Board on Health Sciences Policy; Forum on Neuroscience and Nervous System Disorders; Stroud C, Bain L, editors. Advancing Gene-Targeted Therapies for Central Nervous System Disorders: Proceedings of a Workshop. Washington (DC): National Academies Press (US); 2019 Sep 20.
Advancing Gene-Targeted Therapies for Central Nervous System Disorders: Proceedings of a Workshop.
Show details- JOHN KRYSTAL (Co-Chair), Yale University
- STORY LANDIS (Co-Chair), Director Emeritus, National Institute of Neurological Disorders and Stroke
- SUSAN AMARA, Society for Neuroscience
- RITA BALICE-GORDON, Sanofi
- KATJA BROSE, Chan Zuckerberg Initiative
- EMERY BROWN, Harvard Medical School and Massachusetts Institute of Technology
- DANIEL BURCH, PPD Biotech
- JOSEPH BUXBAUM, Icahn School of Medicine at Mount Sinai
- SARAH CADDICK, Gatsby Charitable Foundation
- ROSA CANET-AVILES, Foundation for the National Institutes of Health
- MARIA CARRILLO, Alzheimer's Association
- E. ANTONIO CHIOCCA, Harvard Medical School (until July 2019)
- TIMOTHY COETZEE, National Multiple Sclerosis Society
- JONATHAN COHEN, Princeton University
- ROBERT CONLEY, Eli Lilly and Company
- JAMES DESHLER, National Science Foundation
- BILLY DUNN, Food and Drug Administration
- MICHAEL EGAN, Merck Research Laboratories
- JOSHUA GORDON, National Institute of Mental Health
- HENRY T. GREELY, Stanford University (until July 2019)
- RAQUEL GUR, University of Pennsylvania
- MAGALI HAAS, Cohen Veterans Bioscience
- RAMONA HICKS, One Mind
- RICHARD HODES, National Institute on Aging
- STUART HOFFMAN, Department of Veterans Affairs
- STEVEN HYMAN, Broad Institute of Massachusetts Institute of Technology and Harvard University
- FRANCES JENSEN, University of Pennsylvania
- GEORGE KOOB, National Institute on Alcohol Abuse and Alcoholism
- WALTER KOROSHETZ, National Institute of Neurological Disorders and Stroke
- ALAN LESHNER, American Association for the Advancement of Science (Emeritus)
- HUSSEINI MANJI, Janssen Research & Development, LLC
- CAROLINE MONTOJO, The Kavli Foundation
- ATUL PANDE, Tal Medical
- STEVEN PAUL, Voyager Therapeutics
- EMILIANGELO RATTI, Takeda Pharmaceuticals International, Inc.
- DOUGLAS SHEELEY, National Institute of Dental and Craniofacial Research
- TODD SHERER, The Michael J. Fox Foundation for Parkinson's Research
- DAVID SHURTLEFF, National Center for Complementary and Integrative Health
- PAUL SIEVING, National Eye Institute
- NORA VOLKOW, National Institute on Drug Abuse
- ANDREW WELCHMAN, Wellcome Trust
- DOUG WILLIAMSON, Lundbeck
- STEVIN ZORN, MindImmune Therapeutics, Inc.
Health and Medicine Division Staff
- CLARE STROUD, Forum Director
- SHEENA M. POSEY NORRIS, Program Officer
- PHOENIX WILSON, Senior Program Assistant
- BARDIA MASSOUDKHAN, Financial Associate
- ANDREW M. POPE, Senior Director, Board on Health Sciences Policy
Footnotes
- 1
The National Academies of Sciences, Engineering, and Medicine's forums and roundtables do not issue, review, or approve individual documents. The responsibility for the published Proceedings of a Workshop rests with the workshop rapporteurs and the institution.
- FORUM ON NEUROSCIENCE AND NERVOUS SYSTEM DISORDERS - Advancing Gene-Targeted The...FORUM ON NEUROSCIENCE AND NERVOUS SYSTEM DISORDERS - Advancing Gene-Targeted Therapies for Central Nervous System Disorders
Your browsing activity is empty.
Activity recording is turned off.
See more...